How to resolve AdBlock issue?
X
How to resolve AdBlock issue?
X
Subscribe
How to resolve AdBlock issue?
X
How to resolve AdBlock issue?
X

  • About
  • Feature Archives
  • Pharma News
  • Supplier News
  • Advertise
  • Contact

Drug Pricing: Congress, President, Industry Heat Up Debate

  • February 13, 2019
The policy debate on drug pricing is heating up as the US Senate is scheduled to hold hearings with pharmaceutical industry CEOs later this month. Meanwhile, the Trump Administration has stressed...

Read more

Industry Weighs In on Mfg Issues to Mitigate Drug Shortages

  • February 13, 2019
The formation of the FDA’s Drug Shortage Task Force last year has engendered recommendations by industry stakeholders to mitigate drug shortages, including proposals for production-transparency...

Read more

SPONSORED CONTENT

  • Continuous Flow for APIs and Intermediates (Part 2)

    Continuous Flow for APIs and Intermediates (Part 2)

    Information
    February 13, 2019
    Sponsored by Cambrex
    Cambrex’s Dr. Shawn Conway, Director of Engineering, R&D, outlines how continuous flow processes simplify and break through traditional method limitations to achieve efficiencies in cost, quality and...

    Read More

  • Continuous Flow for APIs & Intermediates (Part 1)

    Continuous Flow for APIs & Intermediates (Part 1)

    Information
    February 6, 2019
    Sponsored by Cambrex
    After a brief history of the continuous flow process, Cambrex’s Jonathan Knight and Fredrik Stenberg discuss its benefits over traditional batch operations – including cost, quality and safety.

    Read More

VIEW ADDITIONAL SPONSORED CONTENT

More DCAT Value Chain Insights Feature Articles

  • Small Molecules Still Leading in New Drug Approvals
  • Changing the Rules of the Game for APIs in the EU
  • The $62-Billion Marriage of Shire and Takeda: The Risks and Rewards
  • Inside the Minds of CEOs: A Global View
  • New Drug Approvals: Which Drugs Made the Mark in 2018?
  • Pharma Outsourcing Outlook: The Only Sure Thing About 2019 is Uncertainty
  • Bristol-Myers Squibb $74-Billion Buy of Celgene: Products, Pipelines, and Manufacturing
  • Read more...

Read all Top Industry News: Click here for Pharma News + Click here for Supplier News.

Top Industry News

FDA Launches Pilot Program for Drug Supply-Chain Security

FDA Oks Sanofi’s Rare-Disease Drug Cablivi

Dr. Reddy’s Cited by FDA for Indian Formulation Mfg Plant

Sanofi Names Chief Digital Officer

Samsung Bioepis, AffaMed Form Biosimilars Licensing Pact for China

How to resolve AdBlock issue?
X

The essential resource on pharmaceutical manufacturing, sourcing/procurement, and supply management provided by the Drug, Chemical & Associated Technologies Association (DCAT) a not-for-profit global business development association.

One Union St., Suite 208
Robbinsville, NJ 08691
+1.609.208.1888
+1.877.640.DCAT
www.dcat.org

 

Login Form

  • Forgot your username?
  • Forgot your password?

© 2019 DCAT | Privacy PolicyLogin